Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Despite the benefits smartphone technology offers, our phones are available to us almost all of the time and excessive smartphone use may be linked to problematic behaviours and mental illness symptoms. Therefore management of our daily screen time is integral to wellbeing in the digital era.

Design: A recent randomised controlled trial (NCT06353451) randomised university students (N = 111) to either reduce their daily phone use (intervention) or continue use as normal (control). Using a cross-over design, the control group later received the intervention. The results demonstrated that reducing smartphone use to <2hrs/day improved self-reported mental health, as compared to a control group with no change in screentime.

Methods: The aim of this paper was a secondary analysis of daily heart rate variability data (HRV) measured with Fitbit devices to assess physiological changes during the intervention. A total of 45 participants provided baseline, intervention and follow-up HRV data. Mental health variables were measured using standardised questionnaires.

Results: A linear multilevel regression indicated HRV significantly declined during the intervention compared to baseline. HRV during the intervention significantly correlated with craving and sleep quality. Conclusions: This may suggest that participants are experiencing a response akin to withdrawal from a behavioural addiction. Importantly, participants reported improved mental wellbeing, suggesting benefits of controlled smartphone use, but our findings provide a deeper insight into the processes underlying reduction in smartphone use and suggest craving and sleep hygiene may be important factors to additionally consider in future studies. ClinicalTrials.gov identifier: NCT06353451.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12360053PMC
http://dx.doi.org/10.1080/21642850.2025.2546376DOI Listing

Publication Analysis

Top Keywords

randomised controlled
8
controlled trial
8
influence smartphone
4
smartphone reduction
4
reduction heart
4
heart rate
4
rate variability
4
variability secondary
4
secondary analysis
4
analysis randomised
4

Similar Publications

Background: Frailty is defined as a biological syndrome characterized by a decreased reserve and resistance to stressors. Frailty is closely related to lifestyle, and improving lifestyle can effectively reduce the incidence of frailty and related adverse events. Multi-component interventions were an effective mean of improving lifestyle, which has been validated in studies of other populations.

View Article and Find Full Text PDF

Background: The high and increasing rate of poor mental health among young people is a matter of global concern. Experiencing poor mental health during this formative stage of life can adversely impact interpersonal relationships, academic and professional performance, and future health and well-being if not addressed early. However, only a few of those in need seek help.

View Article and Find Full Text PDF

Background: Hypertensive disorders of pregnancy (HDP) affect up to 10% of pregnancies and can have adverse short and long-term implications for women and their babies. eHealth interventions include any health service or treatment delivered using the internet and related technology that aims to facilitate, capture, or exchange knowledge. eHealth interventions are increasingly used across many health care settings with improved outcomes.

View Article and Find Full Text PDF

Background: Children in the United States have poor diet quality, increasing their risk for chronic disease burden later in life. Caregivers' feeding behaviors are a critical factor in shaping lifelong dietary habits. The Strong Families Start at Home/Familias Fuertes Comienzan en Casa (SFSH) was a 6-month, home-based, pilot randomized-controlled feasibility trial that aimed to improve the diet quality of 2-5-year-old children and promote positive parental feeding practices among a predominantly Hispanic/Latine sample.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-associated death globally. Second-line therapies are crucial for improving survival and quality of life among individuals suffering from advanced HCC who have not responded to first-line therapies. This study sought to evaluate the safety and efficacy of different second-line therapies for advanced HCC by network meta-analysis.

View Article and Find Full Text PDF